07.11.2007 19:24:00
|
Thomas M. Ryan Named Chairman of the Board of CVS Caremark
CVS Caremark Corporation (NYSE: CVS), today announced that Thomas M.
Ryan, President and Chief Executive Officer, has been named Chairman of
the Board effective immediately. Mr. Ryan will also continue to serve as
President and Chief Executive Officer. Mac Crawford has announced his
retirement from the company’s Board of
Directors and position as Chairman of the Board.
Mr. Ryan commented, "Mac has been a dedicated
and passionate advocate for Caremark over the past nine years. His broad
health care experience, savvy management and business acumen have helped
make Caremark the leading pharmacy benefit manager in the nation. His
vision is what brought Caremark to where it is today, and now our
combined mission to improve health care is what will take us to the next
level.” "It is with great pride that I announce my
retirement from CVS Caremark,” said Mac
Crawford. "I am confident that we have the
right management focused on the right opportunities, and I could not be
more pleased with the progress we have made since we closed the
transaction. Tom Ryan is an exceptional leader who understands health
care, and the tremendous opportunities to help drive positive outcomes
for consumers, clients, and shareholders. Our vision of using the
breadth of our capabilities to reduce complexity and improve health care
outcomes for consumers while lowering costs for payors is being actively
advanced since the merger. There is no question that the company is in
extremely capable hands with Tom and this newly combined CVS Caremark
team.”
Mr. Ryan, 55, has served as President and Chief Executive Officer of CVS
Caremark since March of 2007. He previously served as Chairman,
President and Chief Executive Officer of CVS Corporation.
Mr. Crawford, 58, has been Chairman of the CVS Caremark Board of
Directors since the closing of the CVS Caremark merger. He previously
served as Chairman and Chief Executive Officer of Caremark Rx., Inc.
In addition, the company also announced that its Board of Directors
appointed Terrence Murray as lead Director. He is the former Chairman of
FleetBoston Financial Corporation and served as Chief Executive Officer
of FleetBoston from May 1982 to December 2001. Mr. Murray has served on
the CVS Caremark Board of Directors since the closing of the CVS
Caremark merger. He had previously served on the CVS Corporation Board
of Directors since 1996.
CVS Caremark is the largest provider of prescriptions in the nation. The
Company fills or manages more than 1 billion prescriptions annually.
Through its unmatched breadth of service offerings, CVS Caremark is
transforming the delivery of health care services in the U.S. The
Company is uniquely positioned to effectively manage costs and improve
health care outcomes through its more than 6,200 CVS/pharmacy stores;
its pharmacy benefit management, mail order and specialty pharmacy
division, Caremark Pharmacy Services; its retail-based health clinic
subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General
information about CVS Caremark is available through the Investor
Relations portion of the Company's website, at http://investor.CVS.com,
as well as through the press room portion of the Company's website, at www.cvs.com/pressroom.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu CVS Health Corpmehr Nachrichten
20:05 |
S&P 500-Handel aktuell: S&P 500 notiert am Freitagnachmittag im Minus (finanzen.at) | |
18:04 |
Börse New York: Das macht der S&P 500 am Mittag (finanzen.at) | |
16:04 |
S&P 500-Wert CVS Health-Aktie: So viel Verlust hätte ein CVS Health-Investment von vor 3 Jahren eingebracht (finanzen.at) | |
03.01.25 |
S&P 500-Papier CVS Health-Aktie: So viel Verlust hätte ein CVS Health-Investment von vor einem Jahr eingebracht (finanzen.at) | |
27.12.24 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust wäre bei einem Investment in CVS Health von vor 10 Jahren angefallen (finanzen.at) | |
26.12.24 |
Pluszeichen in New York: S&P 500 am Mittag freundlich (finanzen.at) | |
20.12.24 |
S&P 500-Papier CVS Health-Aktie: So viel Verlust hätte eine Investition in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
18.12.24 |
Verluste in New York: S&P 500 zum Ende des Mittwochshandels in der Verlustzone (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 46,68 | 3,71% |
Indizes in diesem Artikel
S&P 500 | 5 827,04 | -1,54% | |
NYSE US 100 | 16 447,86 | 0,76% |